Preventing adverse events during paediatric cancer treatment: protocol for a multi-site hybrid randomised controlled trial of catheter lock solutions (the CLOCK trial)

Preventing adverse events during paediatric cancer treatment: protocol for a multi-site hybrid randomised controlled trial of catheter lock solutions (the CLOCK trial)

Introduction Central venous access devices (CVADs) are commonly used for the treatment of paediatric cancer patients. Catheter locking is a routine intervention that prevents CVAD-associated adverse events, such as infection, occlusion and thrombosis. While laboratory and clinical data are promising...

Full description

Saved in:
Bibliographic Details
Main Authors: Paul Monagle, Andrew Wood, Robert Ware, Adam Irwin, Joshua Byrnes, Natalie Bradford, Susan Moloney, Michelle Martin, Tricia Kleidon, Andrew Moore, Roni Cole, Fiona Newall, Victoria Gibson, Samantha Keogh, David Eisenstat, Amanda Ullman, Mari Takashima, Elouise Comber, Eloise Borello, Nicole Henson, Philippa Howard, Karen McCleary, Jordana McLean, Michelle Noyes, Gemma Rowan, Amanda St John, Joshua Wolf
Format: Article
Language:English
Published: BMJ Publishing Group 2024-07-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/14/7/e085637.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bmjopen.bmj.com/content/14/7/e085637.full

Similar Items